Original Cannabis Journalism from the Cultivated Team

Original reporting is expensive. Sources, travel, documents, lawyers, and the hours it takes to get a story right rather than first. Sponsorships fund a daily newsletter. They do not fund investigations. Membership does. Become a Cultivated Member today »

Premium

Aug 27, 2026

•

2 min read

Stop conflating legalization and commercialization 🛑

The anti-rescheduling crowd's arguments have a fatal flaw, Jeremy explains.

Jeremy Berke

Premium

Aug 23, 2026

•

4 min read

Kentucky’s medical cannabis market is open. But patients are slow to arrive.

Kentucky’s fledgling medical cannabis industry is contending with limited supply, steep prices, restrictive regulations and a thriving hemp market as it works to attract patients.

Chris Casacchia

Premium

Aug 18, 2026

•

2 min read

Curaleaf’s hostile bid for Aurora is official

Curaleaf is bringing its hostile bid for Aurora directly to shareholders. The prize? Medical cannabis exports to the EU.

Jeremy Berke

Premium

Aug 13, 2026

•

3 min read

Curaleaf CEO Boris Jordan defends hostile Aurora bid: 'We wanted to be friendly'

Curaleaf CEO Boris Jordan says he tried to play nice before taking its $4-per-share Aurora bid public.

Jeremy Berke

Premium

Aug 12, 2026

•

4 min read

Talarico bets on hemp to win over Texas swing voters

The Texas Senate candidate's opposition to the state's new hemp ban shows how cannabis policy still works as a wedge issue in unlikely places.

Natalie Fertig

Premium

Jul 21, 2026

•

4 min read

The DEA's cannabis rescheduling hearing is over. The stage is set for a court battle.

After two weeks of testimony in Virginia on the DEA's plan to move cannabis from Schedule I to Schedule III, the historic hearing has ended and and both supporters and opponents are now positioning for the legal challenge.

Natalie Fertig

Load more